STONERIDGE INC (SRI) Fundamental Analysis & Valuation

NYSE:SRI • US86183P1021

Current stock price

5.36 USD
-0.12 (-2.19%)
At close:
5.36 USD
0 (0%)
After Hours:

This SRI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. SRI Profitability Analysis

1.1 Basic Checks

  • In the past year SRI has reported negative net income.
  • In the past year SRI had a positive cash flow from operations.
  • In the past 5 years SRI reported 4 times negative net income.
  • SRI had a positive operating cash flow in 4 of the past 5 years.
SRI Yearly Net Income VS EBIT VS OCF VS FCFSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

  • With a Return On Assets value of -18.66%, SRI is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
  • The Return On Equity of SRI (-57.20%) is worse than 75.61% of its industry peers.
Industry RankSector Rank
ROA -18.66%
ROE -57.2%
ROIC N/A
ROA(3y)-7.36%
ROA(5y)-4.74%
ROE(3y)-21.91%
ROE(5y)-13.92%
ROIC(3y)N/A
ROIC(5y)N/A
SRI Yearly ROA, ROE, ROICSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

1.3 Margins

  • SRI's Gross Margin of 20.14% is in line compared to the rest of the industry. SRI outperforms 56.10% of its industry peers.
  • In the last couple of years the Gross Margin of SRI has declined.
  • SRI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.74%
GM growth 5Y-3.69%
SRI Yearly Profit, Operating, Gross MarginsSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SRI Health Analysis

2.1 Basic Checks

  • SRI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SRI has more shares outstanding
  • Compared to 5 years ago, SRI has more shares outstanding
  • SRI has a worse debt/assets ratio than last year.
SRI Yearly Shares OutstandingSRI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
SRI Yearly Total Debt VS Total AssetsSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.39 indicates that SRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.39, SRI is doing good in the industry, outperforming 60.98% of the companies in the same industry.
  • The Debt to FCF ratio of SRI is 14.87, which is on the high side as it means it would take SRI, 14.87 years of fcf income to pay off all of its debts.
  • SRI has a Debt to FCF ratio (14.87) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.01 is on the high side and indicates that SRI has dependencies on debt financing.
  • SRI's Debt to Equity ratio of 1.01 is on the low side compared to the rest of the industry. SRI is outperformed by 73.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 14.87
Altman-Z 2.39
ROIC/WACCN/A
WACC9.78%
SRI Yearly LT Debt VS Equity VS FCFSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 2.30 indicates that SRI has no problem at all paying its short term obligations.
  • SRI has a Current ratio of 2.30. This is comparable to the rest of the industry: SRI outperforms 56.10% of its industry peers.
  • A Quick Ratio of 1.45 indicates that SRI should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.45, SRI is doing good in the industry, outperforming 60.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.3
Quick Ratio 1.45
SRI Yearly Current Assets VS Current LiabilitesSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SRI Growth Analysis

3.1 Past

  • SRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -159.57%.
  • The Revenue has decreased by -5.18% in the past year.
  • The Revenue has been growing slightly by 5.86% on average over the past years.
EPS 1Y (TTM)-159.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-194.44%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y-1.45%
Revenue growth 5Y5.86%
Sales Q2Q%-6%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y80.96%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.43%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SRI Yearly Revenue VS EstimatesSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
SRI Yearly EPS VS EstimatesSRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. SRI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SRI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SRI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRI Price Earnings VS Forward Price EarningsSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • SRI's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRI indicates a somewhat cheap valuation: SRI is cheaper than 60.98% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.34
EV/EBITDA 11.53
SRI Per share dataSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SRI Dividend Analysis

5.1 Amount

  • No dividends for SRI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SRI Fundamentals: All Metrics, Ratios and Statistics

STONERIDGE INC

NYSE:SRI (3/25/2026, 8:04:00 PM)

After market: 5.36 0 (0%)

5.36

-0.12 (-2.19%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)03-11
Earnings (Next)04-28
Inst Owners86.64%
Inst Owner Change-0.67%
Ins Owners2.21%
Ins Owner Change7.96%
Market Cap150.19M
Revenue(TTM)861.26M
Net Income(TTM)-102.83M
Analysts84
Price Target16.32 (204.48%)
Short Float %1.16%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.38%
Min Revenue beat(2)-4.05%
Max Revenue beat(2)1.3%
Revenue beat(4)3
Avg Revenue beat(4)0.49%
Min Revenue beat(4)-4.05%
Max Revenue beat(4)2.92%
Revenue beat(8)4
Avg Revenue beat(8)-0.7%
Revenue beat(12)6
Avg Revenue beat(12)0.37%
Revenue beat(16)10
Avg Revenue beat(16)2.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-188.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF 12.34
P/OCF 4.41
P/B 0.84
P/tB 1.44
EV/EBITDA 11.53
EPS(TTM)-1.22
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.43
FCFY8.1%
OCF(TTM)1.21
OCFY22.65%
SpS30.74
BVpS6.42
TBVpS3.72
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.66%
ROE -57.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.14%
FCFM 1.41%
ROA(3y)-7.36%
ROA(5y)-4.74%
ROE(3y)-21.91%
ROE(5y)-13.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.74%
GM growth 5Y-3.69%
F-Score4
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 14.87
Debt/EBITDA 7.78
Cap/Depr 64.86%
Cap/Sales 2.54%
Interest Coverage N/A
Cash Conversion 146.2%
Profit Quality N/A
Current Ratio 2.3
Quick Ratio 1.45
Altman-Z 2.39
F-Score4
WACC9.78%
ROIC/WACCN/A
Cap/Depr(3y)81.56%
Cap/Depr(5y)82.82%
Cap/Sales(3y)3.05%
Cap/Sales(5y)3.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-159.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-194.44%
EPS Next Y80.96%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y-1.45%
Revenue growth 5Y5.86%
Sales Q2Q%-6%
Revenue Next Year6.43%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-560.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year471.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.75%
OCF growth 3Y70.98%
OCF growth 5Y3.5%

STONERIDGE INC / SRI Fundamental Analysis FAQ

What is the fundamental rating for SRI stock?

ChartMill assigns a fundamental rating of 2 / 10 to SRI.


Can you provide the valuation status for STONERIDGE INC?

ChartMill assigns a valuation rating of 1 / 10 to STONERIDGE INC (SRI). This can be considered as Overvalued.


How profitable is STONERIDGE INC (SRI) stock?

STONERIDGE INC (SRI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for SRI stock?

The Earnings per Share (EPS) of STONERIDGE INC (SRI) is expected to grow by 80.96% in the next year.